Crossmark

Open questions: why should we care about ER-phagy and ER remodelling?

Crossref DOI link: https://doi.org/10.1186/s12915-018-0603-7

Published Online: 2018-11-01

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dikic, Ivan
License Information

Text and Data Mining valid from 2018-11-01
More Information

Article History

First Online: 1 November 2018

Competing interests

: Ivan Dikic is a Visiting Scholar at Genentech Inc. (South San Francisco, USA) and a Consultant of Rheostat Therapeutics Inc.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.